Deep resolution of clinical, cellular and transcriptomic inflammatory markers of psoriasis over 52 weeks of interleukin-17A inhibition by secukinumab.
- DOI
- 10.1093/ced/llae006
- Published
- 2024 Jul 19
- Container
- Clinical and experimental dermatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ced/llae006,
title = {Deep resolution of clinical, cellular and transcriptomic inflammatory markers of psoriasis over 52 weeks of interleukin-17A inhibition by secukinumab.},
author = {Tomalin LE and Kolbinger F and Suprun M and Wharton KA Jr and Hartmann N and Peters T and Glueck A and Milutinovic M and Krueger JG and Suárez-Fariñas M},
year = {2024},
journal = {Clinical and experimental dermatology},
doi = {10.1093/ced/llae006},
url = {https://doi.org/10.1093/ced/llae006}
}RIS
TY - JOUR TI - Deep resolution of clinical, cellular and transcriptomic inflammatory markers of psoriasis over 52 weeks of interleukin-17A inhibition by secukinumab. AU - Tomalin LE AU - Kolbinger F AU - Suprun M AU - Wharton KA Jr AU - Hartmann N AU - Peters T AU - Glueck A AU - Milutinovic M AU - Krueger JG AU - Suárez-Fariñas M PY - 2024 JO - Clinical and experimental dermatology DO - 10.1093/ced/llae006 UR - https://doi.org/10.1093/ced/llae006 ER -
APA
LE, T., F, K., M, S., Jr, W. K., N, H., T, P., A, G., M, M., JG, K., & M, S. (2024). Deep resolution of clinical, cellular and transcriptomic inflammatory markers of psoriasis over 52 weeks of interleukin-17A inhibition by secukinumab.. Clinical and experimental dermatology. https://doi.org/10.1093/ced/llae006
Source records
- pubmed · retrieved 2026-09-27T01:16:37.922Z